Tredje AP-fonden’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-68,541
Closed -$2.97M 396
2025
Q1
$2.97M Buy
68,541
+54,461
+387% +$2.76M 0.03% 182
2024
Q4
$791K Sell
14,080
-14,080
-50% -$876K 0.01% 432
2024
Q3
$1.92M Hold
28,160
0.02% 382
2024
Q2
$1.19M Sell
28,160
-444
-2% -$24.4K 0.01% 428
2024
Q1
$1.98M Hold
28,604
0.02% 368
2023
Q4
$2.12M Sell
28,604
-1,275
-4% -$83.6K 0.03% 369
2023
Q3
$2.04M Sell
29,879
-2,288
-7% -$194K 0.03% 356
2023
Q2
$3.02M Sell
32,167
-5,510
-15% -$430K 0.04% 291
2023
Q1
$2.55M Buy
37,677
+1,903
+5% +$122K 0.04% 330
2022
Q4
$1.77M Buy
35,774
+388
+1% +$15.9K 0.03% 396
2022
Q3
$1.15M Buy
+35,386
New +$1.46M 0.02% 445

Other funds holding EXAS

Tredje AP-fonden's EXAS Position: Q2 2025 in Review

Tredje AP-fonden sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 68,541 shares — an estimated $2.97M sold.

Tredje AP-fonden first reported a position in EXAS in Q3 2022 and held it in 11 quarters. The position peaked at $3.02M in Q2 2023. 559 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Tredje AP-fonden reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Tredje AP-fonden sold 68,541 Exact Sciences shares in Q2 2025, an estimated $2.97M.
  • Tredje AP-fonden first reported a position in Exact Sciences in Q3 2022 and held it in 11 quarters.
  • Tredje AP-fonden's Exact Sciences position peaked at $3.02M in Q2 2023.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Tredje AP-fonden's 13F filing for Q2 2025, filed 5 Aug 2025.